ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

Spending Measures Include Provisions On Ethics For NIH Extramural Scientists.

July 11, 2008

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

July 25, 2014

IOM Finds Insufficient Evidence to Link Polio Vaccine, Cancer

October 25, 2002

In Brief: MSK Opens Laurence Rockefeller Pavilion; Bush Event raised 410 Million for Anderson

July 9, 1999

Two founding cancer center directors step down: Harold Moses at Vanderbilt-Ingram and Charles Coltman at CTRC.

November 19, 2004

Henry Kaplan Was One Of The Century’s Top Scientists, DeVita Says

March 23, 1984